{
    "Case 1": {
        "1": {
            "question": " Describe the patient personal information.  ",
            "answer": " A 36-year-old male doctor with no underlying medical illness or allergies was administered the first dose of the COVID-19 vaccine (Cominarty, BNT162b2, Pfizer-BioNTech) in a tertiary hospital in Malaysia.\n",
            "cleaned_answer": [
                "A 36-year-old male doctor with no underlying medical illness or allergies was administered the first dose of the COVID-19 vaccine (Cominarty, BNT162b2, Pfizer-BioNTech) in a tertiary hospital in Malaysia."
            ]
        },
        "2": {
            "question": " Describe the patient experience.  ",
            "answer": " He presented to the ophthalmology clinic with left eye metamorphopsia 10 days after vaccination. He claimed to have bilateral metamorphopsia with generalized body aches about 3 h postvaccination. His myalgia and backache resolved after 1 day, and his right eye metamorphopsia resolved after 3 days. However, the metamorphopsia in his left eye persisted. Prior to this episode, he did not have any ocular symptoms. There was no eye pain, redness, or photophobia in either eye. No viral-like illness or symptoms, such as cough, upper respiratory tract illness, or fever, were reported before or after his vaccination. At 15 days postvaccination, the patient reported some improvement of the metamorphopsia in his left eye. Although it was still present, the symptoms had reduced in intensity, and the visual acuity had improved to 6/6 OU. At 1-month postvaccination, his symptoms improved with minimal residual metamorphopsia on the Amsler grid with a reduction in the area involved. His visual acuity was 6/6 OU. We diagnosed his ocular symptoms as possibly vaccine-related, and our patient subsequently opted not to continue with the second dose of his vaccine.\n",
            "cleaned_answer": [
                "He presented to the ophthalmology clinic with left eye metamorphopsia 10 days after vaccination.",
                "He claimed to have bilateral metamorphopsia with generalized body aches about 3 h postvaccination.",
                "His myalgia and backache resolved after 1 day, and his right eye metamorphosia resolved after 3 days.",
                "However, the metamorphopsia in his left eye persisted.",
                "Prior to this episode, he did not have any ocular symptoms.",
                "There was no eye pain, redness, or photophobia in either eye.",
                "No viral-like illness or symptoms, such as cough, upper respiratory tract illness, or fever, were reported before or after his vaccination.",
                "At 15 days postvaccination, the patient reported some improvement of the metamorphopsia in his left eye.",
                "Although it was still present, the symptoms had reduced in intensity, and the visual acuity had improved to 6/6 OU.",
                "At 1-month postvaccination, his symptoms improved with minimal residual metamorphopsia on the Amsler grid with a reduction in the area involved.",
                "His visual acuity was 6/6 OU.",
                "We diagnosed his ocular symptoms as possibly vaccine-related, and our patient subsequently opted not to continue with the second dose of his vaccine."
            ]
        },
        "3": {
            "question": " Did you notice any symptoms, such as a fever, cough, or respiratory issues?  ",
            "answer": " There was no eye pain, redness, or photophobia in either eye. No viral-like illness or symptoms, such as cough, upper respiratory tract illness, or fever, were reported before or after his vaccination.\n",
            "cleaned_answer": [
                "There was no eye pain, redness, or photophobia in either eye.",
                "No viral-like illness or symptoms, such as cough, upper respiratory tract illness, or fever, were reported before or after his vaccination."
            ]
        },
        "4": {
            "question": " What’s imaging (only provided the figure explanation here) suggest?  ",
            "answer": " (A) Fundus photograph, autofluorescence and ocular coherence tomography findings at 10 days post vaccination. There is left eye yellowish raised elevation and hyperautofluorescence at the fovea with dome-shaped elevation of the RPE at the fovea causing disruption of the ellipsoid zone. No subretinal fluid was noted. (B) Fundus photograph, ocular coherence tomography (OCT), fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) of the same patient at 15 days post vaccination showed improvement clinically. The yellowish elevated lesion at the fovea had reduced in size, corresponding to the reported improvement in symptoms. The lesion from OCT was still present. There was hyperfluorescence at the macula in venous phase of FFA and hypocyanescence at the macula on ICGA.\n",
            "cleaned_answer": [
                "(A) Fundus photograph, autofluorescence and ocular coherence tomography findings at 10 days post vaccination.",
                "There is left eye yellowish raised elevation and hyperautofluorescence at the fovea with dome-shaped elevation of the RPE at the fovea causing disruption of the ellipsoid zone.",
                "No subretinal fluid was noted.",
                "(B) Fundus photograph, ocular coherence tomography (OCT), fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) of the same patient at 15 days post vaccination showed improvement clinically.",
                "The yellowish elevated lesion at the fovea had reduced in size, corresponding to the reported improvement in symptoms.",
                "The lesion from OCT was still present.",
                "There was hyperfluroescence at the macula in venous phase of FFA and hypocyanescence at the macula on ICGA."
            ]
        },
        "5": {
            "question": " What’s examination suggest?  ",
            "answer": " His presenting visual acuity was 6/12 OU unaided. The refractive assessment showed bilateral low myope of −0.75D and mild astigmatism of −0.25D in the left eye, with a normal amplitude of accommodation 7.5D OU. The best corrected visual acuity was 6/6 OU. Left-eye metamorphopsia was noted on the Amsler chart, mostly around the central and paracentral regions. There was no central scotoma, macropsia, or micropsia. The anterior segment examination via slit lamp biomicroscopy was unremarkable. There was no evidence to suggest ocular inflammation. Fundus examination of the left eye showed a well-circumscribed, yellowish-raised elevation superior to the fovea. No subretinal fluid, exudates, drusen, or hemorrhages were seen. Examination of the right eye was unremarkable (Figure 1A). Fundus examination showed a slight improvement in the size of the lesion at the macula. OCT findings demonstrated a similar lesion at the fovea involving the retinal pigment epithelium. A fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) were performed. The former demonstrated hyperfluorescence at the fovea in the venous phase, corresponding to the fundus findings and OCT images. There was no evidence of leakage, pooling, or neovascularization. ICGA showed hypocyanescence at the corresponding area on the fovea, with a hypocyanescent area noted at the inferonasal vessel arcade in the venous phase. No polyps, branching vascular networks, or evidence of choroidal neovascularization were seen (Figure 1B). However, the anatomical lesion persisted with residual pigment epithelial defect (PED).\n",
            "cleaned_answer": [
                "His presenting visual acuity was 6/12 OU unaided.",
                "The refractive assessment showed bilateral low myope of −0.75D and mild astigmatism of −0.25D in the left eye, with a normal amplitude of accommodation 7.5D OU.",
                "The best corrected visual acuity was 6/6 OU.",
                "Left-eye metamorphopsia was noted on the Amsler chart, mostly around the central and paracentral regions.",
                "There was no central scotoma, macropsia, or micropsia.",
                "The anterior segment examination via slit lamp biomicroscopy was unremarkable.",
                "There was no evidence to suggest ocular inflammation.",
                "Fundus examination of the left eye showed a well-circumscribed, yellowish-raised elevation superior to the fovea.",
                "No subretinal fluid, exudates, drusen, or hemorrhages were seen.",
                "Examination of the right eye was unremarkable (Figure 1A).",
                "Fundus examination showed a slight improvement in the size of the lesion at the macula.",
                "OCT findings demonstrated a similar lesion at the fovea involving the retinal pigment epithelium.",
                "A fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) were performed.",
                "The former demonstrated hyperfluorescence at the fovea in the venous phase, corresponding to the fundus findings and OCT images.",
                "There was no evidence of leakage, pooling, or neovascularization.",
                "ICGA showed hypocyanescence at the corresponding area on the fovea, with a hypocyanescent area noted at the inferonasal vessel arcade in the venous phase.",
                "No polyps, branching vascular networks, or evidence of choroidal neovascularization were seen (Figure 1B).",
                "However, the anatomical lesion persisted with residual pigment epithelial defect (PED)."
            ]
        },
        "6": {
            "question": " Is any suggestions?  ",
            "answer": " $No$”",
            "cleaned_answer": [
                "$No$”"
            ]
        }
    },
    "Case 2": {
        "1": {
            "question": " Describe the patient personal information.  ",
            "answer": " A 68-year-old Malay man.\n",
            "cleaned_answer": [
                "A 68-year-old Malay man."
            ]
        },
        "2": {
            "question": " Describe the patient experience.  ",
            "answer": " Presented with sudden-onset right-eye central blurring of vision 3 days after receiving his second dose of COVID-19 vaccination (Cominarty, BNT162b2, Pfizer-BioNTech). He had no underlying medical illness and no significant past ocular history. He did not have any ocular symptoms after his first dose of the vaccine.\n",
            "cleaned_answer": [
                "A 68-year-old Malay man presented with sudden-onset right-eye central blurring of vision 3 days after receiving his second dose of COVID-19 vaccination (Cominarty, BNT162b2, Pfizer-BioNTech).",
                "He had no underlying medical illness and no significant past ocular history.",
                "He did not have any ocular symptoms after his first dose of the vaccine."
            ]
        },
        "3": {
            "question": " Did you notice any symptoms, such as a fever, cough, or respiratory issues?  ",
            "answer": " $No$\n",
            "cleaned_answer": [
                "$No$"
            ]
        },
        "4": {
            "question": " What’s imaging (only provided the figure explanation here) suggest?  ",
            "answer": " There was no drusen or evidence of age-related macular degeneration, and no myopic changes. Ocular coherence tomography (Topcon Spectral Domain OCT) showed loss of foveal contour with the presence of intraretinal and subretinal fluid, and a fibrovascular pigment epithelial defect (Figure 2A). Following intravitreal ranibizumab injection 1 week later, his right-eye vision remained the same at 6/12 best-corrected. OCT macula revealed resolution of intraretinal fluids; however, the subretinal fluid was similar in size and the fibrovascular PED was more defined (Figure 2B).\n",
            "cleaned_answer": [
                "There was no drusen or evidence of age-related macular degeneration, and no myopic changes.",
                "Ocular coherence tomography (Topcon Spectral Domain OCT) showed loss of foveal contour with the presence of intraretinal and subretinal fluid, and a fibrovascular pigment epithelial defect (Figure 2A).",
                "Following intravitreal ranibizumab injection 1 week later, his right-eye vision remained the same at 6/12 best-corrected.",
                "OCT macula revealed resolution of intraretinal fluids; however, the subretinal fluid was similar in size and the fibrovascular PED was more defined (Figure 2B)."
            ]
        },
        "5": {
            "question": " What’s examination suggest?  ",
            "answer": " His presenting visual acuity was 6/12 OD and 6/6 OS. The anterior segment examination was unremarkable. Fundus examination showed an orange-round lesion at the macula.\n",
            "cleaned_answer": [
                "His presenting visual acuity was 6/12 OD and 6/6 OS.",
                "The anterior segment examination was unremarkable.",
                "Fundus examination showed an orange-round lesion at the macula."
            ]
        },
        "6": {
            "question": " Is any suggestions?  ",
            "answer": " $No$\"",
            "cleaned_answer": [
                "$No$\""
            ]
        }
    },
    "Case 3": {
        "1": {
            "question": " Describe the patient personal information.  ",
            "answer": " A 50-year-old Malay woman with no underlying medical illness presented with bilateral blurring of vision 2 weeks after receiving her second dose of COVID-19 vaccination (Cominarty, BNT162b2, Pfizer-BioNTech).\n",
            "cleaned_answer": [
                "A 50-year-old Malay woman with no underlying medical illness presented with bilateral blurring of vision 2 weeks after receiving her second dose of COVID-19 vaccination (Cominarty, BNT162b2, Pfizer-BioNTech)."
            ]
        },
        "2": {
            "question": " Describe the patient experience.  ",
            "answer": " Her blurring of vision started 1 week after vaccination and did not improve over time. Her visual acuity was 6/18 OD and 6/12 OS. Upon subsequent review, her macula edema and placoid lesions resolved 4 days later. A week after being given intravenous methylprednisolone, her symptoms resolved. Her visual acuity was 6/6 OU, with no macula edema or placoid lesions seen both clinically and on ocular imaging (Figure 3B).\n",
            "cleaned_answer": [
                "Her blurring of vision started 1 week after vaccination and did not improve over time.",
                "Her visual acuity was 6/18 OD and 6/12 OS.",
                "Upon subsequent review, her macula edema and placoid lesions resolved 4 days later.",
                "A week after being given intravenous methylprednisolone, her symptoms resolved.",
                "Her visual acuity was 6/6 OU, with no macula edema or placoid lesions seen both clinically and on ocular imaging (Figure 3B)."
            ]
        },
        "3": {
            "question": " Did you notice any symptoms, such as a fever, cough, or respiratory issues?  ",
            "answer": " $No$\n",
            "cleaned_answer": [
                "$No$"
            ]
        },
        "4": {
            "question": " What’s imaging (only provided the figure explanation here) suggest?  ",
            "answer": " (A)Fundus photo and OCT macula showing bilateral placoid lesions in the choroid with macula edema on presentation. (B)Fundus photo and OCT macula showing resolution of bilateral placoid lesions and macula edema one week post-treatment with intravenous methylprednisolone.\n",
            "cleaned_answer": [
                "(A)Fundus photo and OCT macula showing bilateral placoid lesions in the choroid with macula edema on presentation.",
                "(B)Fundus photo and OCT macula showing resolution of bilateral placoid lesions and macula edema one week post-treatment with intravenous methylprednisolone."
            ]
        },
        "5": {
            "question": " What’s examination suggest?  ",
            "answer": " The anterior segment examination was unremarkable, with no evidence of anterior segment inflammation. Posterior segment examination showed bilateral fibrinous placoid lesions in the choroid with severe inner and outer macula edema (Figure 3A). Visual evoked potential and optic nerve conduction studies were normal. The systemic examination was otherwise unremarkable.\n",
            "cleaned_answer": [
                "The anterior segment examination was unremarkable, with no evidence of anterior segment inflammation.",
                "Posterior segment examination showed bilateral fibrinous placoid lesions in the choroid with severe inner and outer macula edema (Figure 3A).",
                "Visual evoked potential and optic nerve conduction studies were normal.",
                "The systemic examination was otherwise unremarkable."
            ]
        },
        "6": {
            "question": " Is any suggestions?  ",
            "answer": " A diagnosis of acute multifocal placoid pigment epitheliopathy was made based on clinical and investigational findings.\"",
            "cleaned_answer": [
                "A diagnosis of acute multifocal placoid pigment epitheliopathy was made based on clinical and investigational findings.\""
            ]
        }
    },
    "Case 4": {
        "1": {
            "question": " Describe the patient personal information.  ",
            "answer": " A 32-year-old Malay woman who is a housewife with an underlying history of anxiety, panic disorder, and depression received her first dose of Oxford AstraZeneca ChAdOx1 COVID-19 vaccination.\n",
            "cleaned_answer": [
                "A 32-year-old Malay woman who is a housewife with an underlying history of anxiety, panic disorder, and depression received her first dose of Oxford AstraZeneca ChAdOx1 COVID-19 vaccination."
            ]
        },
        "2": {
            "question": " Describe the patient experience.  ",
            "answer": " Two weeks after her vaccination, she developed multiple skin rashes, vesicles, and crusty lesions over the right side of her face, respecting the midline and involving the tip of the nose. A week later, following the onset of the rash, she developed sudden-onset redness, itchiness, and mild blurring of vision in her right eye. There was also right periorbital swelling, which resolved after 2 days.\n",
            "cleaned_answer": [
                "Two weeks after her vaccination, she developed multiple skin rashes, vesicles, and crusty lesions over the right side of her face, respecting the midline and involving the tip of the nose.",
                "A week later, following the onset of the rash, she developed sudden-onset redness, itchiness, and mild blurring of vision in her right eye.",
                "There was also right periorbital swelling, which resolved after 2 days."
            ]
        },
        "3": {
            "question": " Did you notice any symptoms, such as a fever, cough, or respiratory issues?  ",
            "answer": " $No$\n",
            "cleaned_answer": [
                "$No$"
            ]
        },
        "4": {
            "question": " What’s imaging (only provided the figure explanation here) suggest?  ",
            "answer": " $No$\n",
            "cleaned_answer": [
                "$No$"
            ]
        },
        "5": {
            "question": " What’s examination suggest?  ",
            "answer": " Her visual acuity was 6/12 unaided and 6/6 pinhole OU. An ocular examination showed the presence of a circumciliary injection in her right eye. Corneal sensation was intact and equal bilaterally. There was no evidence of cornea epithelial, stromal, or endothelial involvement. Intraocular pressure was 14 mmHg OU. The anterior chamber showed cell activity at 2+ with no keratic precipitates, hypopyons, or fibrinous reactions. Fundus examination was otherwise unremarkable, with normal optic disc and macula. There was no evidence of posterior segment inflammation such as vitritis, retinitis, choroiditis, or vasculitis. Examination of the left eye was normal.\n",
            "cleaned_answer": [
                "Her visual acuity was 6/12 unaided and 6/6 pinhole OU.",
                "An ocular examination showed the presence of a circumciliary injection in her right eye.",
                "Corneal sensation was intact and equal bilaterally.",
                "There was no evidence of cornea epithelial, stromal, or endothelial involvement.",
                "Intraocular pressure was 14 mmHg OU.",
                "The anterior chamber showed cell activity at 2+ with no keratic precipitates, hypopyons, or fibrinous reactions.",
                "Fundus examination was otherwise unremarkable, with normal optic disc and macula.",
                "There was no evidence of posterior segment inflammation such as vitritis, retinitis, choroiditis, or vasculitis.",
                "Examination of the left eye was normal."
            ]
        },
        "6": {
            "question": " Is any suggestions?  ",
            "answer": " She was treated for an underlying herpes zoster infection with right acute nongranulomatous anterior uveitis. The diagnosis was made clinically. She was treated with oral acyclovir at 800 mg five times a day, together with topical tobramycin at 0.3% and dexamethasone at 0.1% 4-hourly in her right eye. Following treatment, the uveitis and skin lesions improved by two weeks and completely resolved at the 1-month follow-up.”",
            "cleaned_answer": [
                "She was treated for an underlying herpes zoster infection with right acute nongranulomatous anterior uveitis.",
                "The diagnosis was made clinically.",
                "She was treated with oral acyclovir at 800 mg five times a day, together with topical tobramycin at 0.3% and dexamethasone at 0.1% 4-hourly in her right eye.",
                "Following treatment, the uveitis and skin lesions improved by two weeks and completely resolved at the 1-month follow-up.”"
            ]
        }
    }
}